Justin Stebbing
Justin Stebbing is a British clinician-scientist specialising in oncology and cancer research.
≈ 2 min read
Justin Stebbing. encyclopegia.org, snapshot enwiki-001368844159. /a/justin-stebbing
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Justin Stebbing is a British clinician-scientist specialising in oncology and cancer research. He is a professor of biomedical sciences at Anglia Ruskin University and practices with the private sector Phoenix Hospital Group in London. Stebbing is co-Editor-in-Chief of the journal Oncogene. He is also a visiting professor of cancer medicine and oncology at Imperial College London.
Cancer research
Stebbing was an oncology professor at Imperial College London and has gained a reputation for innovative treatments. He is co-Editor-in-Chief of the journal Oncogene. The charity Action Against Cancer was set up to support Stebbing's work.
Stebbing's research in cancer has included work on the molecular biology of solid tumours. His group identified LMTK3 as an oncogene and therapeutic target in breast cancer. The team characterised the network of microRNAs induced by the estrogen receptor.
Stebbing has also worked on cancers caused by HIV and AIDS, including investigating immune reconstitution inflammatory syndrome in patients with Kaposi's Sarcoma. He has undertaken extensive work on biosimilars, cheaper versions of expensive biologic drugs designed to democratise access to these.
Other research
Stebbing has worked on neurological therapies for patients with unmet medical needs who are treatment resistant or unresponsive to other existing medications.
Clinical practice
Stebbing is a Fellow of the Royal College of Physicians, the American Society for Clinical Investigation and the Royal College of Pathologists. As a clinician-scientist at Imperial College London, Stebbing practiced with the Imperial College Healthcare NHS Trust at Charing Cross Hospital and Hammersmith Hospital. He resigned his permanent position at Imperial in March 2022.
He has also practiced privately in Harley Street. Patients who experienced successful treatments in his care included Michael Parkinson and Lynda Bellingham. As of 2024, he practices with the private Phoenix Hospital Group, where he specialises in a range of solid malignancies, including difficult cases with few conventional options.
He is also working at the Lauriston Clinic in London.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1368844159 under CC BY-SA 4.0; modifications have been made.